Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cervical Cancer
  Free Subscription

Articles published in
Int J Gynecol Cancer
    April 2024
  1. SHI V, Grover S, Huang Y, Thaker PH, et al
    Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
    Int J Gynecol Cancer. 2024 Apr 29:ijgc-2024-005303.
    >> Share

  2. CHARNALIA M, Chopra S, Mulani J, Popat P, et al
    RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2024-005336.
    >> Share

  3. ROSATI A, Certelli C, Ferrandina G, Fanfani F, et al
    Minimally invasive adrenalectomy: a personalized surgical approach in recurrent cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2023-005241.
    >> Share

  4. KOHLER C, Plaikner A, Siegler K, Hertel H, et al
    Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 10:ijgc-2024-005274.
    >> Share

  5. HANEY K, Ismail-Pratt I, Ng JS, Schmeler KM, et al
    The International Gynecologic Cancer Society Preinvasive Certificate Program: building a skilled workforce for the detection and treatment of cervical pre-cancer.
    Int J Gynecol Cancer. 2024;34:637-638.
    >> Share

  6. KEMAH BL, Bhagat N, Pandya A, Sullivan R, et al
    Training the gynecologic oncologists of the future - challenges and opportunities.
    Int J Gynecol Cancer. 2024;34:619-626.
    >> Share

    March 2024
  7. WESS B, Kohler C, Plaikner A, El-Safadi S, et al
    Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 14:ijgc-2023-005206.
    >> Share

  8. DEL M, Illac C, Morisseau M, Angeles MA, et al
    Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 12:ijgc-2023-004677.
    >> Share

  9. JAYRAJ AS, Singhal S
    The beginning of the end for cervical cancer in India.
    Int J Gynecol Cancer. 2024 Mar 7:ijgc-2024-005420. doi: 10.1136/ijgc-2024-005420
    >> Share

  10. VIVEROS-CARRENO D, Pareja R, Plante M
    De-escalation of surgical radicality for non-fertility preserving management in patients with early-stage cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2024;34:386-392.
    >> Share

  11. PETERS I, Marchetti C, Scambia G, Fagotti A, et al
    New windows of surgical opportunity for gynecological cancers in the era of targeted therapies.
    Int J Gynecol Cancer. 2024;34:352-362.
    >> Share

    February 2024
  12. FOTOPOULOU C, Eriksson AG, Planchamp F, Morice P, et al
    European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management.
    Int J Gynecol Cancer. 2024 Feb 23:ijgc-2024-005293.
    >> Share

  13. BIZZARRI N, Obermair A, Hsu HC, Chacon E, et al
    Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
    Int J Gynecol Cancer. 2024 Feb 20:ijgc-2023-005151.
    >> Share

  14. VAZQUEZ-VICENTE D, Boria F, Castellanos T, Gutierrez M, et al
    SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
    Int J Gynecol Cancer. 2024;34:203-208.
    >> Share

    January 2024
  15. LAAN J, van Lonkhuijzen L, Hinnen K, Pieters B, et al
    Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer.
    Int J Gynecol Cancer. 2024 Jan 17:ijgc-2023-005024.
    >> Share

    December 2023
  16. RIBEIRO R, Baiocchi G, Moretti-Marques R, Linhares JC, et al
    Uterine transposition for fertility and ovarian function preservation after radiotherapy.
    Int J Gynecol Cancer. 2023;33:1837-1842.
    >> Share

  17. PARPINEL G, Laas-Faron E, Balaya V, Guani B, et al
    Survival after sentinel lymph node biopsy for early cervical cancers: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2023;33:1853-1860.
    >> Share

  18. PLAIKNER A, Siegler K, Kohler C
    Surgical steps of laparoscopic-assisted simple vaginal trachelectomy.
    Int J Gynecol Cancer. 2023;33:1972-1973.
    >> Share

    November 2023
  19. BORGHI C, Biagioli E, Mauro J, Roberto A, et al
    Neoadjuvant chemotherapy prior to radical hysterectomy in locally advanced cervical cancer: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2023 Nov 27:ijgc-2023-004863.
    >> Share

  20. CARUSO G, Bruni S, Lapresa M, De Vitis LA, et al
    Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review.
    Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004928.
    >> Share

  21. PARIDA P, Baburaj G, Rao M, Lewis S, et al
    Circulating cell-free DNA as a diagnostic and prognostic marker for cervical cancer.
    Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004873.
    >> Share

  22. KOUHEN F, El Ghanmi A
    Breaking the silence: the taboo surrounding HPV vaccination in Morocco.
    Int J Gynecol Cancer. 2023;33:1835.
    >> Share

  23. NITECKI R, Ramirez PT, Dundr P, Nemejcova K, et al
    MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
    Int J Gynecol Cancer. 2023;33:1684-1689.
    >> Share

  24. ALLANSON ER, Burling M, Simcock B, Nicklin J, et al
    The Australian Society of Gynaecological Oncology Western Pacific Liaison group.
    Int J Gynecol Cancer. 2023;33:1819-1820.
    >> Share

    October 2023
  25. SALCEDO MP, Lathrop E, Osman N, Neves A, et al
    The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique.
    Int J Gynecol Cancer. 2023 Oct 31:ijgc-2023-004958.
    >> Share

  26. XIA L, Wang J, Wang C, Zhang Q, et al
    Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study.
    Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004705.
    >> Share

  27. FRUMOVITZ M, Morani AC, Aziz A, Jhingran A, et al
    PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
    Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004907.
    >> Share

  28. MBURU A, Shaffi AF
    Pathological pelvic fracture due to metastatic cervical cancer in a young immunosuppressed woman.
    Int J Gynecol Cancer. 2023 Oct 19:ijgc-2023-004479.
    >> Share

    September 2023
  29. BIZZARRI N, Russo L, Dolciami M, Zormpas-Petridis K, et al
    Radiomics systematic review in cervical cancer: gynecological oncologists' perspective.
    Int J Gynecol Cancer. 2023 Sep 15:ijgc-2023-004589.
    >> Share

  30. PLAIKNER A, Siegler K, Hertel H, Jacob A, et al
    Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
    Int J Gynecol Cancer. 2023 Sep 11:ijgc-2023-004669.
    >> Share

  31. TURCO LC, Pedone Anchora L, Scambia G, Ferrandina G, et al
    Response to: Correspondence on "Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery" by Yuce Sari et al.
    Int J Gynecol Cancer. 2023;33:1491-1492.
    >> Share

  32. YUCE SARI S, Bay M, Gultekin M
    Correspondence on 'Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery' by Turco et al.
    Int J Gynecol Cancer. 2023;33:1490.
    >> Share

  33. NAKISIGE C, de Fouw M, Kabukye J, Sultanov M, et al
    Artificial intelligence and visual inspection in cervical cancer screening.
    Int J Gynecol Cancer. 2023 Sep 4:ijgc-2023-004397. doi: 10.1136/ijgc-2023-004397
    >> Share

  34. SALVO G, Flores Legarreta A, Ramalingam P, Jhingran A, et al
    Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
    Int J Gynecol Cancer. 2023;33:1359-1369.
    >> Share

  35. MICHAAN N, Wenkert A, Even-Sapir E, Kerzhner K, et al
    Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer.
    Int J Gynecol Cancer. 2023 Sep 1:ijgc-2023-004703. doi: 10.1136/ijgc-2023-004703
    >> Share

    August 2023
  36. MAURO J, Viveros-Carreno D, Vizzielli G, De Ponti E, et al
    Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2023 Aug 16:ijgc-2023-004692.
    >> Share

  37. GONZALEZ-OCHOA E, Milosevic M, Corr B, Abbruzzese JL, et al
    A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
    Int J Gynecol Cancer. 2023;33:1208-1214.
    >> Share

    July 2023
  38. BOGANI G, Ghelardi A, Sopracordevole F, Annoni M, et al
    Human papillomavirus (HPV) vaccination: a call for action in Italy.
    Int J Gynecol Cancer. 2023;33:1132-1139.
    >> Share

    June 2023
  39. OBERMAIR A, Leitao M
    Correspondence on "ESGO/ESTRO/ESP guidelines fpr the management of patients with cervical cancer: update 2023" by Cibula et al.
    Int J Gynecol Cancer. 2023 Jun 15:ijgc-2023-004645.
    >> Share

  40. PAREJA R, Heredia F, Leitao M
    Correspondence on 'ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023*'.
    Int J Gynecol Cancer. 2023 Jun 9:ijgc-2023-004656. doi: 10.1136/ijgc-2023-004656
    >> Share

  41. KOBAYASHI E, Takekuma M, Enomoto T, Okamoto A, et al
    Response to: Commentary on "Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081S-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081" by Ramirez et al.
    Int J Gynecol Cancer. 2023;33:1012.
    >> Share

  42. CORDOBA A, El Hajj H, Martinez-Gomez C, Hudry D, et al
    Should the cut-off for concomitant radiochemotherapy and intracavitary 3D adaptive uterovaginal brachytherapy be 3 cm?
    Int J Gynecol Cancer. 2023;33:1010-1011.
    >> Share

  43. CASTILLO MH, Rodriguez R, Chavez C, Baltazar D, et al
    Control and management of gynecological cancer in Peru.
    Int J Gynecol Cancer. 2023;33:995-996.
    >> Share

  44. NGUYEN CGT, Phillips S, Chen A, Harrison R, et al
    Isolated tumor cells in a patient with early-stage cervical cancer.
    Int J Gynecol Cancer. 2023 Jun 2:ijgc-2022-004115. doi: 10.1136/ijgc-2022-004115
    >> Share

    May 2023
  45. CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al
    ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
    Int J Gynecol Cancer. 2023 May 31:ijgc-2022-004180.
    >> Share

  46. ZHANG X, Wang Y, Lv X, Wang F, et al
    Intratumoral injection of oncolytic virus (H101) in combination with concurrent chemoradiotherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2023 May 19:ijgc-2022-003914.
    >> Share

  47. VIVEROS-CARRENO D, Vieira-Serna S, Grillo-Ardila CF, Rodriguez J, et al
    Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2023 May 16:ijgc-2023-004465.
    >> Share

  48. CIBULA D, Raspollini MR, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Int J Gynecol Cancer. 2023;33:649-666.
    >> Share

  49. ISHIKAWA M, Shibata T, Kataoka T, Takekuma M, et al
    Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinom
    Int J Gynecol Cancer. 2023;33:692-700.
    >> Share

  50. PELEG HASSON S, Felder S, Helpman L, Taylor A, et al
    Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
    Int J Gynecol Cancer. 2023;33:683-691.
    >> Share

  51. CUSCHIERI K, Fellner MD, Arroyo Muhr LS, Padalko E, et al
    Quality assurance in human papillomavirus testing for primary cervical screening.
    Int J Gynecol Cancer. 2023;33:802-811.
    >> Share

  52. LEVYTSKA K, Pena SR, Brown J, Yu Z, et al
    Opioid and benzodiazepine use in gynecologic oncology patients.
    Int J Gynecol Cancer. 2023;33:786-791.
    >> Share

    April 2023
  53. BUDA A, Fanfani F
    The patterns of growth of cervical cancer: a challenge to personalized radical surgery.
    Int J Gynecol Cancer. 2023 Apr 25:ijgc-2023-004556.
    >> Share

  54. RAMIREZ PT
    ESGO/ESTRO/ESP updated guidelines in cervical cancer.
    Int J Gynecol Cancer. 2023 Apr 13:ijgc-2023-004523.
    >> Share

  55. SAGAE S, Toita T, Matsuura M, Saito M, et al
    Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.
    Int J Gynecol Cancer. 2023 Apr 11:ijgc-2022-004230.
    >> Share

  56. TOUHAMI O, Plante M, St-Gelais J, Frumovitz M, et al
    Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix.
    Int J Gynecol Cancer. 2023;33:623-627.
    >> Share

  57. KESIC V, Carcopino X, Preti M, Vieira-Baptista P, et al
    The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus s
    Int J Gynecol Cancer. 2023;33:446-461.
    >> Share

  58. KAMANI MO, Kyrgiou M, Joura E, Zapardiel I, et al
    ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
    Int J Gynecol Cancer. 2023;33:462-464.
    >> Share

  59. GOMEZ CHEREY JF, Payalef SN, Fleider L, Reyes AP, et al
    Microbiota unbalance in relation to high-risk human papillomavirus cervical infection.
    Int J Gynecol Cancer. 2023;33:482-488.
    >> Share

  60. BOCCIOLONE L, Candotti G, Cioffi R, Rabaiotti E, et al
    Sentinel lymph node biopsy in open surgery for gynecological malignancies.
    Int J Gynecol Cancer. 2023;33:636-637.
    >> Share

    March 2023
  61. SOOCHIT A, Zhang C, Feng Y, Luo X, et al
    Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer.
    Int J Gynecol Cancer. 2023 Mar 31:ijgc-2022-004234.
    >> Share

  62. CAPOZZI VA, Rotondella I, De Finis A, Scarpelli E, et al
    Rectovaginal fistula repair by Martius flap after exclusive chemoradiation in a patient with advanced cervical cancer.
    Int J Gynecol Cancer. 2023 Mar 23:ijgc-2023-004365.
    >> Share

  63. OBERMAIR A, Pareja R
    Can simple hysterectomy replace radical hysterectomy as treatment of early-stage cervical cancer?
    Int J Gynecol Cancer. 2023 Mar 10:ijgc-2023-004372.
    >> Share

  64. VIVEROS-CARRENO D, Fernandes A, Pareja R
    Updates on cervical cancer prevention.
    Int J Gynecol Cancer. 2023;33:394-402.
    >> Share

  65. GRAU JF, Farinas-Madrid L, Garcia-Duran C, Garcia-Illescas D, et al
    Advances in immunotherapy in cervical cancer.
    Int J Gynecol Cancer. 2023;33:403-413.
    >> Share

  66. CHELARIU-RAICU A, Mahner S, Moore KN, Lorusso D, et al
    Integrating antibody drug conjugates in the management of gynecologic cancers.
    Int J Gynecol Cancer. 2023;33:420-429.
    >> Share

    February 2023
  67. WEYL A, Chollet C, Gabiache E, Cances-Lauwers V, et al
    PET-MRI for evaluation of response to radiochemotherapy in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2023 Feb 23:ijgc-2022-003958.
    >> Share

  68. ROBINSON EF, Darby JP, Moulder JK
    Cervical cancer screening: missed opportunities in a one-track model.
    Int J Gynecol Cancer. 2023 Feb 7:ijgc-2023-004311. doi: 10.1136/ijgc-2023-004311
    >> Share

  69. CHARGARI C, Nout RA, Lindegaard J, Morice P, et al
    Can we improve survival with less overall morbidity for patients with intermediate-risk cervical cancer without the use of external beam radiotherapy?
    Int J Gynecol Cancer. 2023 Feb 7:ijgc-2023-004305. doi: 10.1136/ijgc-2023-004305
    >> Share


  70. Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer.
    Int J Gynecol Cancer. 2023;33:316.
    >> Share


  71. Correction: The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
    Int J Gynecol Cancer. 2023;33:317-318.
    >> Share

  72. ZAPARDIEL I, Ceccaroni M, Minig L, Halaska MJ, et al
    Avascular spaces in radical hysterectomy.
    Int J Gynecol Cancer. 2023;33:285-292.
    >> Share

    January 2023
  73. TURCO LC, Pedone Anchora L, Fedele C, Inzani F, et al
    Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
    Int J Gynecol Cancer. 2023 Jan 31:ijgc-2022-003940.
    >> Share

  74. MARTINEZ A, Lecuru F, Bizzarri N, Chargari C, et al
    PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.
    Int J Gynecol Cancer. 2023 Jan 30:ijgc-2022-004223.
    >> Share

  75. CARNEIRO VCG, Batista TP, Andrade MR, Barros AV, et al
    Proof-of-concept randomized phase II non-inferiority trial of simple versus type B2 hysterectomy in early-stage cervical cancer
    Int J Gynecol Cancer. 2023 Jan 25:ijgc-2022-004092.
    >> Share

  76. CHIVA L, Gonzalez-Rodriguez M, Tendobi C
    Elikia: a hope for cervical cancer in the Democratic Republic of Congo.
    Int J Gynecol Cancer. 2023 Jan 17:ijgc-2022-004220.
    >> Share

  77. SNYMAN LC, Richter KL, Lukhwareni A, Dreyer G, et al
    Cytology compared with Hybrid Capture 2 human papilloma virus cervical cancer screening in HIV positive and HIV negative South African women.
    Int J Gynecol Cancer. 2023 Jan 17:ijgc-2022-003897.
    >> Share

    December 2022
  78. ROBLES-MORALES R, Morril KE, Lopez-Pentecost M, Madhivanan P, et al
    Arizona-Sonora binational data sharing: the missing piece to the cervical cancer puzzle.
    Int J Gynecol Cancer. 2022 Dec 21:ijgc-2022-004181.
    >> Share

  79. SUZUKI Y, Huang Y, Ferris J, Kulkarni A, et al
    Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause.
    Int J Gynecol Cancer. 2022 Dec 21:ijgc-2022-003861.
    >> Share

  80. CHEN Y, Zheng Y, Wang Q, Dai S, et al
    Transumbilical laparoendoscopic single-site radical trachelectomy with uterine arteries' ascending branches preservation for early-stage cervical cancer.
    Int J Gynecol Cancer. 2022 Dec 16:ijgc-2022-003887.
    >> Share


  81. Correction: The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
    Int J Gynecol Cancer. 2022;32:1635.
    >> Share

  82. LEJEUNE C, Trozzi R, Mearadji B, Painter R, et al
    Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery.
    Int J Gynecol Cancer. 2022;32:1611-1614.
    >> Share

  83. BAE BK, Cho WK, Kim BG, Choi CH, et al
    Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification.
    Int J Gynecol Cancer. 2022;32:1524-1530.
    >> Share

  84. HOEGL J, Viveros-Carreno D, Palacios T, Gallego-Ardila A, et al
    Peritoneal carcinomatosis after minimally invasive surgery versus open radical hysterectomy: systematic review and meta-analysis.
    Int J Gynecol Cancer. 2022;32:1497-1504.
    >> Share

  85. BOHN JA, Fitch KC, Currier JJ, Bruegl A, et al
    HPV self-collection: what are we waiting for? Exploration of attitudes from frontline healthcare providers.
    Int J Gynecol Cancer. 2022;32:1519-1523.
    >> Share

  86. GUANI B, Balaya V, Ayoubi JM, Feki A, et al
    Laparoscopic vaginal radical trachelectomy in the post-LACC era: step-by-step surgical procedure.
    Int J Gynecol Cancer. 2022;32:1617-1618.
    >> Share

    November 2022
  87. DZINAMARIRA T, Moyo E, Dzobo M, Mbunge E, et al
    Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
    Int J Gynecol Cancer. 2022 Nov 11. pii: ijgc-2022-003957.
    >> Share

  88. OYMAK E, Guler OC, Onal C
    Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy.
    Int J Gynecol Cancer. 2022 Nov 10. pii: ijgc-2022-003768.
    >> Share

  89. SALVO G, Ramalingam P, Bhosale P, Frumovitz M, et al
    Advanced stage (FIGO IVB) neuroendocrine cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:1469-1474.
    >> Share

  90. SELCUK I
    Correspondence on 'Simplified anatomical nomenclature of lateral female pelvic spaces' by Querleu et al.
    Int J Gynecol Cancer. 2022;32:1495.
    >> Share

  91. CHIVA L, Gonzalez-Rodriguez M, Tendobi C
    Locally advanced vulvar carcinoma diagnosed during cervical cancer screening.
    Int J Gynecol Cancer. 2022;32:1492.
    >> Share

  92. DOMINGO S, Balasubbaiah Y, Nyndala S, Garcia I, et al
    Surgical training and cervical screening in rural India hospitals.
    Int J Gynecol Cancer. 2022;32:1475-1476.
    >> Share

    October 2022
  93. DATTA GD, Mayrand MH, Glenn BA
    Correspondence on "The increasing incidence of stage IV cervical cancer in the USA: what factors are related?" by Francoeur et al.
    Int J Gynecol Cancer. 2022 Oct 28. pii: ijgc-2022-004066.
    >> Share

  94. MONK BJ, Tan DSP, Hernandez Chagui JD, Takyar J, et al
    Proportions and incidence of locally advanced cervical cancer: a global systematic literature review.
    Int J Gynecol Cancer. 2022 Oct 14. pii: ijgc-2022-003801.
    >> Share

  95. GAO H, Wu H, Zhang Y, Chen Z, et al
    Locoregional therapy for oligometastatic cervical cancer: a single-center retrospective study.
    Int J Gynecol Cancer. 2022 Oct 13. pii: ijgc-2022-003620.
    >> Share

  96. TON M, Swami N, Germar MJV, Dee EC, et al
    HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries.
    Int J Gynecol Cancer. 2022 Oct 11. pii: ijgc-2022-003959.
    >> Share

  97. KOTHA NV, Williamson CW, Marra KV, McHale M, et al
    Incomplete cisplatin regimens in chemoradiation and its effect on outcomes for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2022 Oct 6. pii: ijgc-2022-003766.
    >> Share

  98. ROY M, Finch L, Kwon D, Jordan SE, et al
    Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida population.
    Int J Gynecol Cancer. 2022 Oct 5. pii: ijgc-2022-003475.
    >> Share

  99. RODRIGUEZ J, Viveros-Carreno D, Pareja R
    Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update?
    Int J Gynecol Cancer. 2022;32:1219-1226.
    >> Share

  100. BORIA F, Chiva L, Chacon E, Zanagnolo V, et al
    SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer.
    Int J Gynecol Cancer. 2022;32:1236-1243.
    >> Share

    September 2022
  101. CALO C, Barrington DA, Mclaughlin EM, Bixel K, et al
    Help wanted: low provider density is associated with advanced stage cervical cancer.
    Int J Gynecol Cancer. 2022 Sep 28. pii: ijgc-2022-003779.
    >> Share

  102. CAPISTRANO I R, Paul S, Boere I, Pantziarka P, et al
    Drug repurposing as a potential source of innovative therapies in cervical cancer.
    Int J Gynecol Cancer. 2022 Sep 22. pii: ijgc-2022-003585.
    >> Share

  103. MARTINEZ A, Diaz-Feijoo B, Querleu D
    Para-aortic lymphadenectomy in cervical cancer deserves a new trial.
    Int J Gynecol Cancer. 2022 Sep 16. pii: ijgc-2022-003910.
    >> Share

  104. CIBULA D, Borcinova M, Kocian R, Feltl D, et al
    CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16).
    Int J Gynecol Cancer. 2022 Sep 13. pii: ijgc-2022-003918.
    >> Share

  105. CIBULA D
    Early-stage intermediate-risk-the group with the most heterogenous management among patients with cervical cancer.
    Int J Gynecol Cancer. 2022 Sep 13. pii: ijgc-2022-003908.
    >> Share

    August 2022
  106. GLICKMAN A, Diaz-Feijoo B, Agusti N, Carreras-Dieguez N, et al
    Laparoscopically assisted radical vaginal hysterectomy in early-stage cervical cancer.
    Int J Gynecol Cancer. 2022 Aug 22. pii: ijgc-2022-003670.
    >> Share

  107. FRANCOEUR AA, Liao CI, Casear MA, Chan A, et al
    The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
    Int J Gynecol Cancer. 2022 Aug 18. pii: ijgc-2022-003728.
    >> Share

  108. NOBREGA L, Zanon JR, Andrade CEEMDC, Schmidt RL, et al
    Prognostic role of hydronephrosis in the treatment of patients with locally advanced cervical cancer: a retrospective cohort.
    Int J Gynecol Cancer. 2022 Aug 16. pii: ijgc-2022-003679.
    >> Share

    July 2022
  109. TENDOBI C, Fernandez-Marques M, Carlos S, Amann M, et al
    Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in Kinshasa, Democratic Republic of Congo.
    Int J Gynecol Cancer. 2022 Jul 20. pii: ijgc-2022-003592.
    >> Share

  110. HUEPENBECKER S, Santia MC, Harrison R, Dos Reis R, et al
    Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer.
    Int J Gynecol Cancer. 2022 Jul 8. pii: ijgc-2022-003654.
    >> Share

  111. NASIOUDIS D, Rush M, Taunk NK, Ko EM, et al
    Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation.
    Int J Gynecol Cancer. 2022;32:823-827.
    >> Share

  112. PAREJA R
    Surgical staging for locally-advanced cervical cancer: the answer remains 'NO'.
    Int J Gynecol Cancer. 2022;32:828-829.
    >> Share

  113. TOWNER M, Kim JJ, Simon MA, Matei D, et al
    Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States.
    Int J Gynecol Cancer. 2022;32:931-938.
    >> Share

    June 2022
  114. PFAENDLER KS, Williams HJ
    Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy.
    Int J Gynecol Cancer. 2022;32:815-816.
    >> Share

  115. WAGNER A, Skof AS, Sehouli J, Richter R, et al
    Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
    Int J Gynecol Cancer. 2022;32:716-723.
    >> Share

  116. CHIKAZAWA K, Imai K, Kuwata T, Konno R, et al
    Importance of conization and pathological status.
    Int J Gynecol Cancer. 2022;32:820.
    >> Share

    May 2022
  117. SANSON C, Zaccarini F, Majer M, Pautier P, et al
    Neoadjuvant chemotherapy in fertility-sparing management of FIGO 2018 stage IB2 cervical cancer.
    Int J Gynecol Cancer. 2022;32:680-685.
    >> Share

    April 2022
  118. OLTHOF EP, Wenzel H, van der Velden J, Spijkerboer AM, et al
    Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking.
    Int J Gynecol Cancer. 2022 Apr 28. pii: ijgc-2022-003357.
    >> Share

  119. GARCIA-DURAN C, Grau F, Villacampa G, Oaknin A, et al
    ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation.
    Int J Gynecol Cancer. 2022 Apr 20. pii: ijgc-2022-003370.
    >> Share

  120. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
    Disparities in time to start of definitive radiation treatment for patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2022 Apr 15. pii: ijgc-2021-003305.
    >> Share

  121. TOBONI MD, Cohen A, Gentry ZL, Ostby SA, et al
    Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.
    Int J Gynecol Cancer. 2022 Apr 15. pii: ijgc-2021-003227.
    >> Share


  122. Correction: Human papillomavirus-independent cervical cancer: what are the implications?
    Int J Gynecol Cancer. 2022;32:582.
    >> Share

  123. GLENNON K, Treacy A, Geoghegan T, Downey P, et al
    Endocervical adenocarcinoma in situ with ovarian metastases.
    Int J Gynecol Cancer. 2022;32:566-569.
    >> Share

  124. ANGELES MA, Bizzarri N, Shushkevich A, Gomez-Hidalgo NR, et al
    Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation.
    Int J Gynecol Cancer. 2022;32:468-473.
    >> Share

  125. AGUSTI N, Zorrilla Vaca A, Segarra-Vidal B, Iniesta MD, et al
    Outcomes of open radical hysterectomy following implementation of an enhanced recovery after surgery program.
    Int J Gynecol Cancer. 2022;32:480-485.
    >> Share

    March 2022
  126. LEE J, Lin JB, Chang CL, Jan YT, et al
    Optimal prophylactic para-aortic radiotherapy in locally advanced cervical cancer: anatomy-based versus margin-based delineation.
    Int J Gynecol Cancer. 2022 Mar 30. pii: ijgc-2021-003298.
    >> Share

  127. LI D, Huang S, Liu K, Qin Y, et al
    Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis.
    Int J Gynecol Cancer. 2022 Mar 24. pii: ijgc-2021-003159.
    >> Share

  128. GRACE L, Sanday K, Garrett A, Land R, et al
    Vaginal vault smear cytology in detection of recurrence after hysterectomy for early cervical cancer.
    Int J Gynecol Cancer. 2022 Mar 14. pii: ijgc-2021-003302.
    >> Share

  129. MAYADEV JS, Ke G, Mahantshetty U, Pereira MD, et al
    Global challenges of radiotherapy for the treatment of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2022;32:436-445.
    >> Share

  130. SHERER MV, Kotha NV, Williamson C, Mayadev J, et al
    Advances in immunotherapy for cervical cancer: recent developments and future directions.
    Int J Gynecol Cancer. 2022;32:281-287.
    >> Share

  131. STURDZA AE, Knoth J
    Image-guided brachytherapy in cervical cancer including fractionation.
    Int J Gynecol Cancer. 2022;32:273-280.
    >> Share

  132. MIRIYALA R, Mahantshetty U, Maheshwari A, Gupta S, et al
    Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future.
    Int J Gynecol Cancer. 2022;32:260-265.
    >> Share

  133. TSENG M, Ngoi NY, Tan DS, Tong PS, et al
    Combined modality management of advanced cervical cancer including novel sensitizers.
    Int J Gynecol Cancer. 2022;32:246-259.
    >> Share

  134. PINTO PJJ, Chen MJ, Santos Neto E, Faloppa CC, et al
    Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis.
    Int J Gynecol Cancer. 2022;32:239-245.
    >> Share

  135. CHOU B, Prasad Venkatesulu B, Coleman RL, Harkenrider M, et al
    Management of stage I and II cervical cancer: a review.
    Int J Gynecol Cancer. 2022;32:216-224.
    >> Share

  136. FENLON JB, Rositch AF, Dickey BL, Kimani S, et al
    Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review.
    Int J Gynecol Cancer. 2022;32:429-435.
    >> Share

  137. BHATIA R, Lichter KE, Gurram L, MacDuffie E, et al
    The state of gynecologic radiation therapy in low- and middle-income countries.
    Int J Gynecol Cancer. 2022;32:421-428.
    >> Share

  138. ZHOU Y, Espenel S, Achkar S, Leary A, et al
    Combined modality including novel sensitizers in gynecological cancers.
    Int J Gynecol Cancer. 2022;32:389-401.
    >> Share

  139. DONOVAN EK, Covens AL, Kupets RS, Leung EW, et al
    The role of oophoropexy in patients with gynecological cancer who need radiation therapy.
    Int J Gynecol Cancer. 2022;32:380-388.
    >> Share

  140. KIDD EA
    Imaging to optimize gynecological radiation oncology.
    Int J Gynecol Cancer. 2022;32:358-365.
    >> Share

  141. JHINGRAN A
    Updates in the treatment of vaginal cancer.
    Int J Gynecol Cancer. 2022;32:344-351.
    >> Share

  142. HSU IC, Yoshida E
    Ultrasound guidance for cervical implantation.
    Int J Gynecol Cancer. 2022;32:266-272.
    >> Share

  143. FRANCO I, Viswanathan AN
    Radiation oncology management of stage III and IVA cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:231-238.
    >> Share

  144. CHOPRA S, Ranjan N, Mittal P
    Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future.
    Int J Gynecol Cancer. 2022;32:225-230.
    >> Share

    February 2022
  145. VIVEROS-CARRENO D, Rodriguez J, Rendon Pereira GJ, Slama J, et al
    Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.
    Int J Gynecol Cancer. 2022 Feb 24. pii: ijgc-2021-003297.
    >> Share

  146. MACCHIA G, Nardangeli A, Laliscia C, Fodor A, et al
    Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
    Int J Gynecol Cancer. 2022 Feb 22. pii: ijgc-2021-003237.
    >> Share

  147. REGAUER S, Reich O, Kashofer K
    Correspondence on "Human papillomavirus-independent cervical cancer" by Fernandes et al.
    Int J Gynecol Cancer. 2022 Feb 15. pii: ijgc-2022-003368.
    >> Share

  148. TONINI F, Michel D, Foulon A
    An unusual cause of cervical bleeding.
    Int J Gynecol Cancer. 2022;32:214.
    >> Share

  149. CHACON E, Manzour N, Zanagnolo V, Querleu D, et al
    SUCCOR cone study: conization before radical hysterectomy.
    Int J Gynecol Cancer. 2022;32:117-124.
    >> Share

  150. NASIOUDIS D, Ramirez PT
    Is prior conization the way forward to determine surgical approach? The answer is not so simple!
    Int J Gynecol Cancer. 2022;32:125-126.
    >> Share

  151. SERRA RUBERT A, Climent MT, Llueca Abella A
    Schauta, an old technique for a new discussion.
    Int J Gynecol Cancer. 2022;32:205-206.
    >> Share

    January 2022
  152. ILHAN Y, Tatli AM, Teker F, Onder AH, et al
    Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
    Int J Gynecol Cancer. 2022 Jan 27. pii: ijgc-2021-003165.
    >> Share

  153. DREYER G, Botha MH, Snyman LC, Visser C, et al
    Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials.
    Int J Gynecol Cancer. 2022 Jan 25. pii: ijgc-2021-003079.
    >> Share

  154. IJFF M, Crezee J, Oei AL, Stalpers LJA, et al
    The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review.
    Int J Gynecol Cancer. 2022 Jan 19. pii: ijgc-2021-002473.
    >> Share

  155. BIZZARRI N, Pletnev A, Razumova Z, Zalewski K, et al
    Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO).
    Int J Gynecol Cancer. 2022 Jan 6. pii: ijgc-2021-002812.
    >> Share

  156. PEREZ MONTIEL CA, Varela Aguirre GJ
    Primary non-gestational choriocarcinoma of the uterine cervix.
    Int J Gynecol Cancer. 2022;32:111-112.
    >> Share

  157. GORDHANDAS SB, Kahn R, Sassine D, Aviki EM, et al
    Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
    Int J Gynecol Cancer. 2022;32:79-88.
    >> Share

  158. DAIX M, Angeles MA, Leray H, Vergriete K, et al
    Anterior pelvic exenteration and laterally extended pelvic resection: a step by step procedure.
    Int J Gynecol Cancer. 2022;32:107-108.
    >> Share

  159. DEVAJA O, Papadopoulos AJ, Bharathan R, Montalto SA, et al
    Sentinel lymph node biopsy alone in the management of early cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:15-20.
    >> Share

    December 2021
  160. RODRIGUES AN, de Melo AC, Calabrich AFC, Cronenberger E, et al
    Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215).
    Int J Gynecol Cancer. 2021 Dec 29. pii: ijgc-2021-002972.
    >> Share

  161. DARIN MC, Di Guilmi J, Quiroga Luna J, Maya AG, et al
    Cervical cancer after LACC: a combination of surgical strategies.
    Int J Gynecol Cancer. 2021 Dec 16. pii: ijgc-2021-003042.
    >> Share

  162. BOHN JA, Hernandez-Zepeda ML, Hersh AR, Munro EG, et al
    Does obesity influence the preferred treatment approach for early-stage cervical cancer? A cost-effectiveness analysis.
    Int J Gynecol Cancer. 2021 Dec 9. pii: ijgc-2021-003004.
    >> Share


  163. Correction: Cervical cancer in pregnancy at various gestational ages.
    Int J Gynecol Cancer. 2021;31:1624.
    >> Share

    November 2021
  164. SCHMELER KM, Batman SH
    Human papillomavirus-independent cervical cancer: what are the implications?
    Int J Gynecol Cancer. 2021 Nov 29. pii: ijgc-2021-003250.
    >> Share

  165. POUYEZ C, Dami M
    Gallstone mimicking metastatic cervical cancer.
    Int J Gynecol Cancer. 2021;31:1496.
    >> Share

  166. FERNANDES A, Viveros-Carreno D, Hoegl J, Avila M, et al
    Human papillomavirus-independent cervical cancer.
    Int J Gynecol Cancer. 2021 Nov 1. pii: ijgc-2021-003014.
    >> Share

  167. HARRY V, Persad S, Barrow T, Rattan R, et al
    UK-trained specialists perform first radical trachelectomy in Trinidad and Tobago.
    Int J Gynecol Cancer. 2021;31:1486-1487.
    >> Share

    October 2021
  168. LI J, Gu C, Zheng H, Geng X, et al
    Ultrasonographic diagnosis in rare primary cervical cancer.
    Int J Gynecol Cancer. 2021 Oct 28. pii: ijgc-2021-002860.
    >> Share

  169. VIVEROS-CARRENO D, Rodriguez J, Pareja R
    Incidence of metastasis in circumflex iliac nodes in patients with cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2021 Oct 7. pii: ijgc-2021-003005.
    >> Share


  170. Correction: Infection versus cancer: management of actinomyces mimicking cervical cancer or ovarian cancer.
    Int J Gynecol Cancer. 2021;31:1400.
    >> Share

  171. SOZZI G, Chiantera V
    Vena cava resection and bypass for recurrent cervical cancer.
    Int J Gynecol Cancer. 2021;31:1393.
    >> Share

  172. ODETTO D, Saadi JM, Chacon CB, Wernicke A, et al
    Uterine transposition after radical trachelectomy.
    Int J Gynecol Cancer. 2021;31:1374-1379.
    >> Share

  173. LERAY H, Angeles MA, Daix M, Martinez A, et al
    How to avoid peritoneal tumor spillage during total abdominal hysterectomy in uterine cancers with cervical invasion.
    Int J Gynecol Cancer. 2021;31:1382-1383.
    >> Share

    September 2021
  174. DATTA A, West C, O'Connor JPB, Choudhury A, et al
    Impact of hypoxia on cervical cancer outcomes.
    Int J Gynecol Cancer. 2021 Sep 30. pii: ijgc-2021-002806.
    >> Share

  175. ABU-RUSTUM NR
    ConCerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer, by Schmeler et al.
    Int J Gynecol Cancer. 2021 Sep 24. pii: ijgc-2021-003008.
    >> Share

  176. SCHMELER KM, Pareja R, Lopez Blanco A, Humberto Fregnani J, et al
    ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.
    Int J Gynecol Cancer. 2021 Sep 7. pii: ijgc-2021-002921.
    >> Share

    August 2021
  177. LUVIAN-MORALES J, Flores-Cisneros L, Jimenez-Lima R, Alarcon-Barrios S, et al
    Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer.
    Int J Gynecol Cancer. 2021 Aug 5. pii: ijgc-2021-002720.
    >> Share

  178. SALVO G, Ramalingam P, Bhosale P, Frumovitz M, et al
    Early-stage, high-grade neuroendocrine cervical carcinoma.
    Int J Gynecol Cancer. 2021;31:1179-1183.
    >> Share

  179. NASIOUDIS D, Byrne M, Ko EM, Haggerty AF, et al
    Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database.
    Int J Gynecol Cancer. 2021;31:1099-1103.
    >> Share

    July 2021
  180. BORIA F, Chiva L, Zanagnolo V, Querleu D, et al
    Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators.
    Int J Gynecol Cancer. 2021 Jul 28. pii: ijgc-2021-002587.
    >> Share

  181. GROVER S, Ning MS, Bale M, Lichter KE, et al
    Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
    Int J Gynecol Cancer. 2021 Jul 26. pii: ijgc-2021-002601.
    >> Share

  182. SPENCER NM, Bos L
    Intracardiac metastatic cervical cancer.
    Int J Gynecol Cancer. 2021;31:1095.
    >> Share

  183. NASIOUDIS D, Albright BB, Ko EM, Haggerty AF, et al
    Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2021;31:983-990.
    >> Share

    June 2021
  184. CHILINDA G, Massamba L, Meja S, Ngo C, et al
    Implementing a comprehensive cervical cancer program in Southern Malawi: a 'Medecins Sans Frontieres', Ministry of Health, and College of Medicine of Blantyre Collaborative Project.
    Int J Gynecol Cancer. 2021 Jun 2. pii: ijgc-2021-002743.
    >> Share

  185. NASIOUDIS D, Latif NA, Giuntoli Ii RL, Haggerty AF, et al
    Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors.
    Int J Gynecol Cancer. 2021;31:829-834.
    >> Share

    May 2021
  186. MANZOUR N, Vazquez-Vicente D, Carriles I, Boria F, et al
    Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
    Int J Gynecol Cancer. 2021 May 24. pii: ijgc-2021-002592.
    >> Share

  187. MATSUO K, Nusbaum DJ, Matsuzaki S, Klar M, et al
    Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States.
    Int J Gynecol Cancer. 2021 May 20. pii: ijgc-2021-002655.
    >> Share

  188. KUMAR D, Miriyala R, Rai B, Bansal P, et al
    Impact of three-dimensional chemoradiation on pelvic bone mineral density, low back pain, and disability in cervical cancer: a prospective study.
    Int J Gynecol Cancer. 2021 May 11. pii: ijgc-2020-002290.
    >> Share

  189. WRIGHT JD
    Minimal risk for minimally invasive hysterectomy for stage IA cervical cancer?
    Int J Gynecol Cancer. 2021 May 10. pii: ijgc-2021-002733.
    >> Share

  190. GOMEZ RODRIGO S, Calderon J, Dionisi JN, Santi A, et al
    Cervical cancer in pregnancy at various gestational ages.
    Int J Gynecol Cancer. 2021;31:784-788.
    >> Share

  191. NAVARRO AS, Angeles MA, Migliorelli F, Illac C, et al
    Comparison of SPECT-CT with intraoperative mapping in cervical and uterine malignancies.
    Int J Gynecol Cancer. 2021;31:679-685.
    >> Share

  192. MUALLEM MZ, Miranda A, Muallem J
    Nerve-sparing radical hysterectomy-Muallem technique with explanation of parametrium and paracolpium anatomy.
    Int J Gynecol Cancer. 2021;31:795-796.
    >> Share

    April 2021
  193. MAENE C, Salihi RR, Van Nieuwenhuysen E, Han SN, et al
    Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB-IIB cervical cancer.
    Int J Gynecol Cancer. 2021 Apr 15. pii: ijgc-2021-002432.
    >> Share

  194. CORINTI M, Alvarenga-Bezerra V, Ribeiro R, Liao AW, et al
    Extraperitoneal laparoscopic pelvic lymphadenectomy for cervical cancer staging in twin pregnancy.
    Int J Gynecol Cancer. 2021 Apr 13. pii: ijgc-2021-002410.
    >> Share

  195. CHEN JH, Duan H, Yu XB, Zhao HW, et al
    Clinical features and prognostic factors of cervical villoglandular adenocarcinoma.
    Int J Gynecol Cancer. 2021;31:512-517.
    >> Share

    March 2021
  196. CIBULA D
    Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer.
    Int J Gynecol Cancer. 2021 Mar 18. pii: ijgc-2021-002510.
    >> Share

  197. SORMANI J, Datchoua AM, Petignat P, Kenfack B, et al
    Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon.
    Int J Gynecol Cancer. 2021 Mar 12. pii: ijgc-2021-002555.
    >> Share

  198. FURUSAWA A, Takekuma M, Mori K, Usami T, et al
    A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
    Int J Gynecol Cancer. 2021 Mar 4. pii: ijgc-2020-002344.
    >> Share

  199. LOPEZ A, Rodriguez J, Estrada E, Aragona A, et al
    Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study.
    Int J Gynecol Cancer. 2021;31:468-474.
    >> Share

  200. MARTINELLI F, Ditto A, Filippi F, Vinti D, et al
    Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer.
    Int J Gynecol Cancer. 2021;31:457-461.
    >> Share

  201. FANFANI F, Pedone Anchora L, Di Martino G, Bizzarri N, et al
    Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer.
    Int J Gynecol Cancer. 2021;31:452-456.
    >> Share

  202. NICA A, Marchocki Z, Gien LT, Kupets R, et al
    Cervical conization and lymph node assessment for early stage low-risk cervical cancer.
    Int J Gynecol Cancer. 2021;31:447-451.
    >> Share

  203. NOLL F, Palacios Torres AT, Pecci P, Lucchini SM, et al
    Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
    Int J Gynecol Cancer. 2021;31:379-386.
    >> Share

  204. BUONOMO B, Multinu F, Casarin J, Betella I, et al
    Ovarian transposition in patients with cervical cancer prior to pelvic radiotherapy: a systematic review.
    Int J Gynecol Cancer. 2021;31:360-370.
    >> Share

  205. DOGAN NU, Kohler C, Pfiffer T, Plaikner A, et al
    Prospective assessment of urinary and bowel symptoms, and sexual function between laparoscopic assisted vaginal radical trachelectomy and radical hysterectomy.
    Int J Gynecol Cancer. 2021;31:484-489.
    >> Share

  206. BAIOCCHI G, Vieira M, Moretti-Marques R, Mantoan H, et al
    Uterine transposition for gynecological cancers.
    Int J Gynecol Cancer. 2021;31:442-446.
    >> Share

  207. BURBANO J, Heredia F, Sanabria D, Ardila EG, et al
    Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes.
    Int J Gynecol Cancer. 2021;31:387-398.
    >> Share

  208. STEWART K, Campbell S, Frumovitz M, Ramirez PT, et al
    Fertility considerations prior to conservative management of gynecologic cancers.
    Int J Gynecol Cancer. 2021;31:339-344.
    >> Share

  209. MORO F, Bonanno GM, Gui B, Scambia G, et al
    Imaging modalities in fertility preservation in patients with gynecologic cancers.
    Int J Gynecol Cancer. 2021;31:323-331.
    >> Share

    February 2021
  210. CAMPITELLI M, Lazzari R, Piccolo F, Ferrazza P, et al
    Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review.
    Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2020-002310.
    >> Share

  211. MCCORMACK M, Gaffney D, Tan D, Bennet K, et al
    The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.
    Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2021-002422.
    >> Share

  212. SCOTT AA, Yarney J, Vanderpuye V, Akoto Aidoo C, et al
    Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
    Int J Gynecol Cancer. 2021 Feb 8. pii: ijgc-2020-002120.
    >> Share

  213. STOLNICU S, Boros M, Hoang L, Almadani N, et al
    FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
    Int J Gynecol Cancer. 2021;31:177-184.
    >> Share

    January 2021
  214. RODRIGUEZ J, Rauh-Hain JA, Saenz J, Isla DO, et al
    Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis.
    Int J Gynecol Cancer. 2021 Jan 27. pii: ijgc-2020-002086.
    >> Share

  215. LI L, Wu M
    Pelvic nerves during radical trachelectomy.
    Int J Gynecol Cancer. 2021;31:154.
    >> Share

  216. SAKURAGI N, Kaneuchi M
    Paracervical and paravaginal tissue dissection in the Okabayashi-Kobayashi radical hysterectomy and nerve-sparing technique.
    Int J Gynecol Cancer. 2021;31:145-146.
    >> Share

    December 2020
  217. CAO L, Wen H, Feng Z, Han X, et al
    Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Dec 10. pii: ijgc-2020-001974.
    >> Share

  218. KIM N, Choi SH, Chang JS, Kim YT, et al
    Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer.
    Int J Gynecol Cancer. 2020 Dec 3. pii: ijgc-2020-002031.
    >> Share

  219. MARNITZ S, Tsunoda AT, Martus P, Vieira M, et al
    Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Int J Gynecol Cancer. 2020;30:1855-1861.
    >> Share

    November 2020
  220. RENDON GJ, Lopez Blanco A, Aragona A, Saadi JM, et al
    Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer >/=2 cm.
    Int J Gynecol Cancer. 2020 Nov 16. pii: ijgc-2020-002076.
    >> Share

  221. OLTHOF EP, Mom CH, van der Velden J
    More attention is needed for the corrigendum to the revised FIGO staging for carcinoma of the cervix uteri.
    Int J Gynecol Cancer. 2020;30:1850.
    >> Share

    October 2020
  222. SANTORO A, Angelico G, Inzani F, Arciuolo D, et al
    Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 30. pii: ijgc-2020-001710.
    >> Share

  223. SMALL W JR, Peltecu G, Puiu A, Corha A, et al
    Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference.
    Int J Gynecol Cancer. 2020 Oct 29. pii: ijgc-2020-001652.
    >> Share

  224. PRECI DP, Almeida A, Weiler AL, Mukai Franciosi ML, et al
    Oxidative damage and antioxidants in cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 27. pii: ijgc-2020-001587.
    >> Share

  225. ALLANSON ER, Velanova V, Frazer IH, McAdam M, et al
    An update on cervical cancer screening in Vanuatu.
    Int J Gynecol Cancer. 2020 Oct 26. pii: ijgc-2020-002129.
    >> Share

  226. LIN F, Zheng R, Yu C, Su Y, et al
    Predictive role of serum cholesterol and triglycerides in cervical cancer survival.
    Int J Gynecol Cancer. 2020 Oct 13. pii: ijgc-2020-001333.
    >> Share

  227. BERCOW AS, Nitecki R, Haber H, Gockley AA, et al
    Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 12. pii: ijgc-2020-001812.
    >> Share

  228. NICA A, Kim SR, Gien LT, Covens A, et al
    Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001816.
    >> Share

  229. ANDERSEN B, Njor SH, Jensen AMS, Johansen T, et al
    HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study.
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001457.
    >> Share

  230. HARRISON R, Ramirez PT
    Bronchocutaneous fistula from metastatic cervical cancer with COVID-19.
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001976.
    >> Share

  231. DE CUYPERE M, Lovinfosse P, Gennigens C, Hermesse J, et al
    Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 8. pii: ijgc-2020-001676.
    >> Share

    September 2020
  232. GOVOROV I, Dikareva E, Velichko E, Kesic V, et al
    Human-machine alliance against cervical cancer.
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-002064.
    >> Share

  233. GULTEKIN M, Beduk Esen CS, Balci B, Alanyali S, et al
    Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-001733.
    >> Share

  234. NAGASE Y, Kobayashi E, Takiuchi T, Kodama M, et al
    Challenges of laparoscopic lymphadenectomy for cervical cancer in pregnant women: techniques and tips.
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-001703.
    >> Share

  235. TU H, Huang H, Xian B, Li J, et al
    Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).
    Int J Gynecol Cancer. 2020 Sep 24. pii: ijgc-2020-001857.
    >> Share

    May 2020
  236. VAZQUEZ-VICENTE D, Castellanos T, Cabello A, Chacon E, et al
    Multidisciplinary approach in the pelvic relapse of a previously irradiated cervical tumor.
    Int J Gynecol Cancer. 2020;30:714.
    >> Share

  237. GULTEKIN M, Turan SH, Boztas G, Ozturk C, et al
    Passion for saving lives: Turkey between 2012 and 2017.
    Int J Gynecol Cancer. 2020;30:709-710.
    >> Share

  238. PAREJA R
    Safety of minimally invasive radical hysterectomy in cervical tumors <2 cm.
    Int J Gynecol Cancer. 2020;30:572-574.
    >> Share

    April 2020
  239. CHAMBERS LM, Herrmann A, Michener CM, Ferrando CA, et al
    Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma.
    Int J Gynecol Cancer. 2020;30:515-524.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016